These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6530355)

  • 1. The drug-immune system interaction in cancer therapy.
    Ghione M
    Int J Tissue React; 1984; 6(6):513-21. PubMed ID: 6530355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulation by cancer chemotherapeutic agents and antineoplastic activity.
    Spreafico F; Mantovani A
    Pathobiol Annu; 1981; 11():177-95. PubMed ID: 6460217
    [No Abstract]   [Full Text] [Related]  

  • 3. Twelve immunotherapy drugs that could cure cancers.
    Cheever MA
    Immunol Rev; 2008 Apr; 222():357-68. PubMed ID: 18364014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of nutrition and treatment of cancer on host immunocompetence.
    Ota DM; Copeland EM; Corriere JN; Dudrick SJ
    Surg Gynecol Obstet; 1979 Jan; 148(1):104-11. PubMed ID: 364703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunological aspects of anticancer chemotherapy].
    Zitvogel L; Tesniere A; Apetoh L; Ghiringhelli F; Kroemer G
    Bull Acad Natl Med; 2008 Oct; 192(7):1469-87; discussion 1487-9. PubMed ID: 19445369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Delayed hypersensitivity as a result of successful chemotherapy of neoplasms].
    Jedrzejczak WW
    Wiad Lek; 1980 Apr; 33(7):547-53. PubMed ID: 6967240
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of the effectiveness of selected non-steroidal anti-inflammatory drugs and their derivatives against cancer cells in vitro.
    Andrews P; Zhao X; Allen J; Li F; Chang M
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):203-14. PubMed ID: 17447067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV
    Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer mucosa antigens as a novel immunotherapeutic class of tumor-associated antigen.
    Snook AE; Eisenlohr LC; Rothstein JL; Waldman SA
    Clin Pharmacol Ther; 2007 Dec; 82(6):734-9. PubMed ID: 17898707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
    Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
    Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs.
    Correale P; Del Vecchio MT; La Placa M; Montagnani F; Di Genova G; Savellini GG; Terrosi C; Mannucci S; Giorgi G; Francini G; Cusi MG
    J Immunother; 2008; 31(2):132-47. PubMed ID: 18481383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration.
    Andersen MH; Gehl J; Reker S; Pedersen LØ; Becker JC; Geertsen P; thor Straten P
    Semin Cancer Biol; 2003 Dec; 13(6):449-59. PubMed ID: 15001164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the immunopharmacology of cancer chemotherapeutics.
    Spreafico F
    Behring Inst Mitt; 1984 May; (74):230-8. PubMed ID: 6541034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration.
    Bracci L; Moschella F; Sestili P; La Sorsa V; Valentini M; Canini I; Baccarini S; Maccari S; Ramoni C; Belardelli F; Proietti E
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):644-53. PubMed ID: 17255288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant breast cancer therapy: current status and future strategies--growth kinetics and the improved drug therapy of breast cancer.
    Norton L
    Semin Oncol; 1999 Feb; 26(1 Suppl 3):1-4. PubMed ID: 10203263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological aspects of cancer chemotherapy.
    Zitvogel L; Apetoh L; Ghiringhelli F; Kroemer G
    Nat Rev Immunol; 2008 Jan; 8(1):59-73. PubMed ID: 18097448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of postoperative adjuvant chemotherapy on the immune system in 100 cancer patients.
    Israel L; Samak R; Grefft-Alami A; Edelstein R
    Prog Clin Biol Res; 1983; 132E():35-44. PubMed ID: 6647476
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunogenic anti-cancer chemotherapy as an emerging concept.
    Haynes NM; van der Most RG; Lake RA; Smyth MJ
    Curr Opin Immunol; 2008 Oct; 20(5):545-57. PubMed ID: 18573339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer vaccines: maximizing a suboptimal immune response for improved outcome.
    Slovin SF
    Clin Adv Hematol Oncol; 2007 Dec; 5(12):972-80. PubMed ID: 18277959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.